AxoGen and Blueprint Medicines Help Opaleye Return 91% Over the Last Year
James A. Silverman founded Opaleye Management back in 1996 and it was formerly known as Risk/Reward Capital.
Fund Name: | Opaleye Management |
Manager | James A. Silverman |
Portfolio Value | $321,996,000 |
Change This QTR | +0.68% |
No. | Security | Ticker | Shares | Value (x$1000) | Activity | % Port | History |
---|---|---|---|---|---|---|---|
1. | OCUL | 5,974,800 | $29,575 | 9.18% | |||
2. | CDXS | 1,345,000 | $27,734 | 8.61% | |||
3. | CMRX | 5,903,450 | $27,038 | +6% | 8.39% | ||
4. | Harrow Health Inc | 3,291,343 | $22,447 | +1% | 6.97% | ||
5. | CRNX | 693,000 | $15,211 | -5% | 4.72% |
Symbol | Company | Filed By | Filing Date | Filing |
---|---|---|---|---|
2022-06-10 | ||||
2022-06-03 | ||||
2022-02-18 | ||||
2022-02-01 | ||||
2022-02-01 |